Pacific Smiles Group Ltd (ASX: PSQ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Pacific Smiles Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$168.36 million
P/E Ratio
86.96
Dividend Yield
2.02%
Shares Outstanding
159.58 million
Earnings per share
0.015
Dividend per share
0.05
Year To Date Return
-29.01%
Earnings Yield
1.15%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Pacific Smiles Group Ltd (ASX: PSQ)
Latest News
Earnings Results
4 ASX healthcare shares charging higher on positive earnings updates
Share Market News
5 ASX All Ords shares just upgraded by top brokers
Healthcare Shares
'Highly sought-after': 3 ASX healthcare shares ready to roar again
Broker Notes
'Revenues up 59%': 3 small-cap ASX shares rocketing right now (and set for more gains)
Dividend Investing
4 ASX All Ordinaries shares trading ex-dividend on Wednesday
Frequently Asked Questions
-
Yes, Pacific Smiles Group has historically paid one or two fully franked shareholder dividends a year.
-
Pacific Smiles Group Limited list on the ASX on 21 November 2014.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 21 Sep 2023 | $0.0227 | 100.00% | Final | 09 Oct 2023 |
| 22 Mar 2023 | $0.0035 | 100.00% | Interim | 06 Apr 2023 |
| 24 Mar 2021 | $0.0240 | 100.00% | Interim | 09 Apr 2021 |
| 18 Mar 2020 | $0.0240 | 100.00% | Interim | 01 May 2020 |
| 18 Sep 2019 | $0.0350 | 100.00% | Final | 04 Oct 2019 |
| 18 Mar 2019 | $0.0230 | 100.00% | Interim | 05 Apr 2019 |
| 19 Sep 2018 | $0.0380 | 100.00% | Final | 05 Oct 2018 |
| 16 Mar 2018 | $0.0230 | 100.00% | Interim | 04 Apr 2018 |
| 14 Sep 2017 | $0.0000 | 100.00% | Final | 03 Oct 2017 |
| 15 Sep 2016 | $0.0350 | 100.00% | Final | 04 Oct 2016 |
| 15 Mar 2016 | $0.0200 | 100.00% | Interim | 01 Apr 2016 |
PSQ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Pacific Smiles Group Ltd
Pacific Smiles Group Limited (ASX: PSQ) operates more than 120 dental centres nationally while more than 800 dentists operate their practices under the company's framework. In those practices, Pacific Smiles provides facilities, dental equipment, and support staff, while dental practitioners maintain clinical autonomy. The group owns and operates Pacific Smiles Dental and nib Dental Care centres across Australia's east coast and also manages operations of HBF Dental Centres in Western Australia.
PSQ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 Dec 2023 | $1.06 | $-0.01 | -0.94% | 16,345 | $1.06 | $1.06 | $1.05 |
| 04 Dec 2023 | $1.06 | $0.03 | 2.91% | 23,320 | $1.09 | $1.10 | $1.06 |
| 01 Dec 2023 | $1.03 | $-0.06 | -5.50% | 168,321 | $1.03 | $1.05 | $1.02 |
| 30 Nov 2023 | $1.09 | $0.02 | 1.86% | 25,413 | $1.07 | $1.09 | $1.07 |
| 29 Nov 2023 | $1.08 | $0.16 | 17.49% | 847,984 | $0.91 | $1.08 | $0.91 |
| 28 Nov 2023 | $0.92 | $0.02 | 2.22% | 86,813 | $0.91 | $0.93 | $0.90 |
| 27 Nov 2023 | $0.90 | $-0.02 | -2.17% | 331,811 | $0.94 | $0.94 | $0.90 |
| 24 Nov 2023 | $0.92 | $-0.01 | -1.08% | 1,113,119 | $0.95 | $0.95 | $0.92 |
| 23 Nov 2023 | $0.93 | $-0.16 | -14.81% | 2,943,473 | $1.03 | $1.03 | $0.88 |
| 22 Nov 2023 | $1.08 | $-0.01 | -0.92% | 359 | $1.08 | $1.08 | $1.08 |
| 21 Nov 2023 | $1.09 | $-0.05 | -4.37% | 67,102 | $1.12 | $1.14 | $1.09 |
| 20 Nov 2023 | $1.15 | $0.00 | 0.00% | 1,852 | $1.15 | $1.15 | $1.15 |
| 17 Nov 2023 | $1.15 | $0.04 | 3.60% | 52,389 | $1.11 | $1.15 | $1.06 |
| 16 Nov 2023 | $1.11 | $-0.01 | -0.89% | 892 | $1.11 | $1.11 | $1.11 |
| 15 Nov 2023 | $1.12 | $0.10 | 9.76% | 94,240 | $1.05 | $1.15 | $1.05 |
| 14 Nov 2023 | $1.03 | $-0.01 | -0.97% | 10,205,259 | $1.04 | $1.07 | $1.01 |
| 13 Nov 2023 | $1.03 | $-0.02 | -1.90% | 117,396 | $1.04 | $1.07 | $1.03 |
| 10 Nov 2023 | $1.05 | $-0.02 | -1.87% | 942,586 | $1.07 | $1.07 | $1.05 |
| 09 Nov 2023 | $1.07 | $-0.04 | -3.60% | 212,085 | $1.11 | $1.12 | $1.07 |
| 08 Nov 2023 | $1.11 | $0.01 | 0.91% | 425,879 | $1.10 | $1.14 | $1.05 |
| 07 Nov 2023 | $1.10 | $-0.05 | -4.35% | 138,658 | $1.14 | $1.14 | $1.10 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 27 Nov 2023 | Jodie Leonard | Buy | 22,500 | $20,250 |
On-market trade.
|
| 24 Nov 2023 | Giselle Collins | Buy | 10,000 | $9,450 |
On-market trade.
|
| 24 Nov 2023 | Zita Peach | Buy | 55,000 | $51,095 |
On-market trade.
|
| 24 Nov 2023 | Steven Rubic | Buy | 100,000 | $92,000 |
On-market trade.
|
| 29 Aug 2023 | Zita Peach | Buy | 29,913 | $42,655 |
On-market trade. 50,087 as prior holding, as per announcement on 31-08-2023
|
| 25 Aug 2023 | Jodie Leonard | Buy | 16,000 | $20,800 |
On-market trade.
|
| 23 Aug 2023 | Philip McKenzie | Expiry | 850,000 | $1,075,250 |
As advised by the company. 2,650,000 Performance Rights, Lapse of Performance Rights, As per announcement on 29-08-2023
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Zita Peach | Non-Executive DirectorNon-Executive Chairman | Aug 2017 |
Ms Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries. She has sales and marketing experience across multiple sectors in healthcare, locally and internationally, as well as international expansions and conducting business transactions. Zita was Executive Vice President for South Asia Pacific, Managing Director for Australia and New Zealand and Chair of the Boards for Malaysia, Australia and New Zealand.
|
| Mr Mark Alan Bloom | Non-Executive Director | Oct 2019 |
Mr Bloom's executive career as a Finance Executive has spanned 36 years as Chief Financial Officer and an Executive Director at 3 listed entities in Real Estate. He has experience in running global and local Finance and IT teams encompassing Treasury, Tax, Operations Finance, Compliance, Risk Management, Financial Reporting, Legal and Information Technology.
|
| Ms Jodie Lee Leonard | Non-Executive Director | May 2023 |
Mr Leonard has over 30 years of experience in various marketing roles at firms including GE Capital (as Chief Marketing Officer), Nine Network Australia, Telstra, British Airways, Colgate Palmolive, and Unilever.
|
| Ms Giselle Marie Collins | Non-Executive Director | Nov 2023 |
Ms Collins is a Director with executive experience in property, tourism and financial services, as well as having worked in professional services with KPMG in Sydney, London and Switzerland. Giselle is currently Chair of Hotel Property Investments (ASX:HPI) as well as a Non-Executive Director of Generation Development Group (ASX:GDG) and Cooper Energy (ASX:COE). Giselle is also Chair of the Responsible Entity for AMPs registered managed investment schemes and a Trustee of the Royal Botanic Gardens and Domain Trust until December this year when her term ends. Giselles past board experience includes being the Chair of Aon Superannuation, Chair of the Travelodge Hotel Group and Chair of the Heart Research Institute. She has also served on the Boards of BIG4 Holiday Parks, Vinomofo, ASX listed Peak Rare Earths and the Royal Australian Institute of Architects.
|
| Dr Scott Kalniz | Non-Executive Director | Jan 2021 |
Dr. Kalniz has over 20 years of dental industry experience in the United States. Dr. Kalniz then partnered with a private equity firm, as CEO and Chief Dental Officer, to create a new Chicago headquartered Dental Services Organisation (DSO), Elite Dental Partners.
|
| Mr Steven Rubic | Non-Executive Director | May 2023 |
Mr Rubic has over 30 years of experience in senior leadership roles, most recently as CEO of private healthcare provider Healthscope, and previously CEO of I-MED Radiology Network and St Vincents & Mater Health. He is currently a Non-Executive Director of Healthscope and the Mercy Partners, with previous board experience including Monte Sant Angelo Mercy College, the Garvan Institute of Medical Research, the Chris OBrien Lifehouse, the Macquarie University Council, and the NSW Private Hospitals Association.
|
| Mr Paul Robertson | Interim CEO | Aug 2023 |
-
|
| Ms Belinda Ann Cleminson | Company Secretary | Aug 2021 |
-
|
| Belinda Ann Cleminson | Company Secretary |
-
|
|
| Paul Robertson | Interim CEO |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 41,683,931 | 26.12% |
| JP Morgan Nominees Australia Pty Limited | 19,929,337 | 12.49% |
| Alison J Hughes | 15,797,850 | 9.90% |
| Dr Alexander J Abrahams | 13,296,547 | 8.33% |
| National Nominees Limited | 10,292,867 | 6.45% |
| UBS Nominees Pty Limited | 8,293,207 | 5.20% |
| Citicorp Nominees Pty Limited | 6,412,247 | 4.02% |
| Just Paddling Pty Limited | 3,454,646 | 2.16% |
| Susan L Abrahams | 3,134,314 | 1.96% |
| Robert G Cameron & Paula S Cameron | 2,108,480 | 1.32% |
| Channings Holdings Pty Limited | 2,090,150 | 1.31% |
| Karen Wright | 2,022,000 | 1.27% |
| Sudemo Pty Limited | 1,744,863 | 1.09% |
| Lodka Pty Limited | 1,322,194 | 0.83% |
| Trevor Collins & Dianne E Collins | 1,128,480 | 0.71% |
| Sterling Surgical Pty Limited | 900,000 | 0.56% |
| Dianne A Wheeldon | 789,132 | 0.49% |
| Warbont Nominees Pty Limited | 781,079 | 0.49% |
| Dr David Roessler | 766,200 | 0.48% |
| Levigrad Pty Ltd | 746,936 | 0.47% |
